Related Experiment Video
Updated: Aug 25, 2025

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
Published on: July 25, 2025
An Optimized Treatment Protocol for Subretinal Injections Limits Intravitreal Vector Distribution
Felix F L Reichel1,2, Fabian Wozar1,2, Immanuel Seitz1,2
1University Eye Hospital, Centre for Ophthalmology, University Hospital Tübingen, Tübingen, Germany.
Subretinal injections (SRis) can lead to adeno-associated virus (AAV) spreading into the vitreous. A simple 3-minute lavage significantly reduces this off-target vector load, enhancing gene therapy safety.
Area of Science:
- Ophthalmology
- Gene Therapy
- Molecular Biology
Background:
- Subretinal injections (SRis) are crucial for delivering adeno-associated virus (AAV) in retinal gene therapy.
- Off-target AAV delivery into the vitreous can increase biodistribution and inflammation, potentially compromising safety and efficacy.
- The intravitreal space is less immune-privileged than the subretinal space, making intravitreal AAV a concern.
Purpose of the Study:
- To optimize the surgical protocol for subretinal injections (SRis) to minimize off-target adeno-associated virus (AAV) delivery into the vitreous.
- To reduce the risk of extensive biodistribution and inflammation associated with intravitreal AAV.
- To enhance the overall safety of retinal gene therapy procedures.
Main Methods:
- An experimental animal study was conducted using eight cynomolgus monkeys (Macaca fascicularis).
- Subretinal injections of an AAV2/8 vector were performed at two different viral genome (vg) doses (1x10^11 and 5x10^11 vg).
- Intravitreal fluid samples were collected post-injection and after a 3-minute balanced salt solution (BSS) lavage to quantify vector genome copies using quantitative polymerase chain reaction.
Main Results:
- Even uneventful subretinal injections (SRis) resulted in the dissemination of millions of adeno-associated virus (AAV) particles into the vitreous cavity (0.1-0.7% of the total dose).
- A 3-minute lavage of the intravitreal space with balanced salt solution (BSS) significantly decreased the intravitreal vector load by an average of 96%.
- Quantitative polymerase chain reaction confirmed a substantial reduction in intravitreal vector genome copies after the lavage procedure.
Conclusions:
- Minimizing off-target adeno-associated virus (AAV) application after subretinal injection (SRi) reflux is critical for improving retinal gene therapy safety.
- A simple 3-minute lavage of the intravitreal space effectively reduces the intravitreal vector load.
- This lavage step should be considered an integral part of surgical protocols for subretinal gene therapy to mitigate risks associated with intravitreal vector dissemination.
More Related Videos
06:48Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
07:13An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016